Paragard T 380a (Copper) Drug Interactions: 7 Moderate
Paragard T 380a (Copper) Drug Interactions
Check all documented drug-to-drug interactions. Major, moderate, and minor interactions with descriptions.
A therapy excluded from this list does not necessarily mean no interaction exists between that therapy and Paragard T 380a. Always confirm against the full prescribing information.
7 interactions
Conjugated estrogens
Conjugated estrogens can cause an increase in the absorption of Copper resulting in an increased serum concentration and potentially a worsening of adverse effects.
Level 2 evidence
Estradiol
Estradiol can cause an increase in the absorption of Copper resulting in an increased serum concentration and potentially a worsening of adverse effects.
Level 2 evidence
Estradiol acetate
Estradiol acetate can cause an increase in the absorption of Copper resulting in an increased serum concentration and potentially a worsening of adverse effects.
Level 2 evidence
Estriol
Estriol can cause an increase in the absorption of Copper resulting in an increased serum concentration and potentially a worsening of adverse effects.
Level 2 evidence
Estrone sulfate
Estrone sulfate can cause an increase in the absorption of Copper resulting in an increased serum concentration and potentially a worsening of adverse effects.
Level 2 evidence
Ethinylestradiol
Ethinylestradiol can cause an increase in the absorption of Copper resulting in an increased serum concentration and potentially a worsening of adverse effects.
Level 2 evidence
Zinc ascorbate
The serum concentration of Zinc ascorbate can be decreased when it is combined with Copper.
Paragard T 380a (Copper) has 7 documented drug interactions. Always review the full list with a pharmacist before co-prescribing.
Paragard T 380a (Copper) has 0 major, 7 moderate, and 0 minor documented interactions.
A therapy excluded from this list does not necessarily mean no interaction exists between that therapy and Paragard T 380a. Always confirm against the full prescribing information.